Related Experiment Video
Updated: Feb 23, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
49.5K
Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions
Samuel S Duffy1, Justin G Lees1, Chamini J Perera1
1School of Medical Sciences, the University of New South Wales, UNSW Australia, Sydney, NSW 2052, Australia.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|September 7, 2017
Summary
Neuropathic pain in multiple sclerosis (MS) is difficult to treat. Research into animal models of MS may lead to new drug therapies for this debilitating symptom.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Multiple sclerosis (MS) is a central nervous system (CNS) inflammatory disease.
- Neuropathic pain is a common and challenging symptom in MS patients.
- Specific lesion patterns in MS may cause central neuropathic pain, Lhermitte's phenomenon, and trigeminal neuralgia.
Purpose of the Study:
- To address the lack of effective pharmacological treatments for MS-associated neuropathic pain.
- To explore therapeutic strategies informed by research in peripheral neuropathies and spinal cord injury.
Main Methods:
- Investigated neuropathic pain in experimental autoimmune encephalomyelitis (EAE), an animal model of MS.
- Examined the efficacy of various pharmacological interventions, including cannabinoids and opioids.
- Assessed the effectiveness of conventional analgesics, antidepressants, and anticonvulsants.
Main Results:
- Conventional analgesics provide inadequate relief for MS-related neuropathic pain.
- First-line treatments often include antidepressants and anticonvulsants.
- Alternative therapies like cannabinoids and opioids show variable success.
Conclusions:
- Understanding EAE-induced neuropathic pain mechanisms is crucial.
- Investigating novel pharmacological interventions in animal models is a promising research direction.
- This research may guide future therapeutic options for MS neuropathic pain.
Related Concept Videos
01:25Analgesia and Pain Management
2.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.3K
01:28Classification of Skeletal Muscle Relaxants
3.2K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.2K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
837
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
837
01:23Peripheral Artery Disease V: Postoperative Nursing Management
441
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
441
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.7K
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
1.4K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.4K